According to the Bank's website, the project provides funding to Nobel Ilac, a pharmaceutical manufacturer and distributor of pharmaceutical and food supplement products, to finance company's working capital needs due to the impact of Covid-19.
|Private Actor 1||Private Actor 1 Role||Private Actor 1 Sector||Relation||Private Actor 2||Private Actor 2 Role||Private Actor 2 Sector|
|-||-||-||-||Nobel Ilac Sanayii ve Ticaret A.S.||Client||-|
PROJECT CONTACT INFORMATION
Nobel Ilac Sanayii ve Ticaret A.S.
Mrs. Esra Eke
Chief Financial Officer
+90 (216) 633 60 00
Saray Doktor Adnan Buyukdeniz Caddesi Akcakoca Sk. 34768 Umraniye Istanbul Turkiye
ACCESS TO INFORMATION
You can submit a request for information disclosure at: https://disclosures.ifc.org/#/inquiries
If you believe that your request for information from IFC has been unreasonably denied, or that this Policy has been interpreted incorrectly, you can submit a complaint at the link above to IFC's Access to Information Policy Advisor, who reports directly to IFC's Executive Vice President.
ACCOUNTABILITY MECHANISM OF IFC/MIGA
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org